These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38864226)

  • 1. Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial.
    Jackson LR; McKenna K; Corneli A; Dombeck C; Brelsford K; Thomas KL
    Circ Cardiovasc Qual Outcomes; 2024 Jul; 17(7):e010550. PubMed ID: 38864226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology.
    Thomas KL; Sullivan LT; Al-Khatib SM; LaPointe NA; Sears S; Kosinski AS; Jackson LR; Kutyifa V; Peterson ED
    Am Heart J; 2020 Feb; 220():59-67. PubMed ID: 31785550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial.
    Thomas KL; Al-Khatib SM; Kosinski AS; Sears SF; Allen LaPointe NM; Jackson LR; Matlock DD; Haithcock D; Colley BJ; Hirsh DS; Peterson ED
    Ann Intern Med; 2023 May; 176(5):615-623. PubMed ID: 37011387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and Implantable Cardioverter-Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death.
    Boursiquot BC; Young R; Alhanti B; Sullivan LT; Maul AJ; Khedagi A; Sears SF; Jackson LR; Thomas KL
    J Am Heart Assoc; 2024 Jul; 13(14):e033291. PubMed ID: 38979811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial.
    Thomas KL; Zimmer LO; Dai D; Al-Khatib SM; Allen LaPointe NM; Peterson ED
    Am Heart J; 2013 Jul; 166(1):157-63. PubMed ID: 23816035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.
    Hess PL; Matlock DD; Al-Khatib SM
    Clin Cardiol; 2020 Feb; 43(2):187-195. PubMed ID: 31867773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' perceptions of shared decision-making for implantable cardioverter-defibrillators: Results of a physician survey.
    Ali-Ahmed F; Matlock D; Zeitler EP; Thomas KL; Haines DE; Al-Khatib SM
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2420-2426. PubMed ID: 31515880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.
    Pokorney SD; Hellkamp AS; Yancy CW; Curtis LH; Hammill SC; Peterson ED; Masoudi FA; Bhatt DL; Al-Khalidi HR; Heidenreich PA; Anstrom KJ; Fonarow GC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):145-51. PubMed ID: 25504649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race, Trust, and Medical Decision-Making for Implantable Cardioverter Defibrillators: Do Black Patients Trust the Messenger?
    Markson F; Kwaku KF
    Circ Cardiovasc Qual Outcomes; 2024 Jul; 17(7):e011142. PubMed ID: 38864204
    [No Abstract]   [Full Text] [Related]  

  • 10. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.
    Masoudi FA; Go AS; Magid DJ; Cassidy-Bushrow AE; Doris JM; Fiocchi F; Garcia-Montilla R; Glenn KA; Goldberg RJ; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Jackson N; Kadish A; Lauer M; Miller AW; Multerer D; Peterson PN; Reifler LM; Reynolds K; Saczynski JS; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Greenlee RT
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):e78-85. PubMed ID: 23170006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial.
    Carroll SL; McGillion M; Stacey D; Healey JS; Browne G; Arthur HM; Thabane L
    Trials; 2013 Oct; 14():346. PubMed ID: 24148851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators.
    Reeder HT; Shen C; Buxton AE; Haneuse SJ; Kramer DB
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005675. PubMed ID: 31412732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
    Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
    Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of government-mandated shared decision-making for implantable defibrillators: A natural experiment.
    Rao BR; Merchant FM; Abernethy ER; Howard DH; Matlock DD; Dickert NW
    Pacing Clin Electrophysiol; 2022 Feb; 45(2):274-280. PubMed ID: 34843128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data.
    Wallace BC; Allen LA; Knoepke CE; Glasgow RE; Lewis CL; Fairclough DL; Helmkamp LJ; Fitzgerald MD; Tzou WS; Kramer DB; Varosy PD; Gupta SK; Mandrola JM; Brancato SC; Peterson PN; Matlock DD
    Am Heart J; 2020 Aug; 226():161-173. PubMed ID: 32599257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.